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Abstract 
L-type Cav 1.3 calcium channels perform critical functions in auditory hair cells, 
cardiac pacemaker cells, and pancreatic ~-cells , but little is currently known about how 
these channels are modulated by cell signaling mechanisms. To begin to address this 
issue, we have tested the ability of various G protein-coupled receptors (GPCRs) to 
modulate Cav 1.3 expressed in a mammalian cell line . Expression plasmids encoding 
Cay 1.3 and auxiliary calcium channel subunits a2-ob and ~3 were transiently 
coexpressed in HEK.293 cells along with plasmids encoding a single type of GPCR. As a 
control for functional expression of the GPCR , we performed parallel transfections of 
separate HEK.293 cells with N-type calcium channels (Cav2.2), which display modulation 
by most GPCRs. Whole-cell patch-clamp recordings were used to monitor calcium 
channel activity under control conditions and during agonist-dependent receptor 
activation. Our results indicate that Gaq/11-coupled receptors (alA-adrenergic, Hl 
histamine, Ml muscarinic acetylcholine, and neurokinin 1 (NKl) receptors) trigger 
profound inhibition of Cav 1.3, whereas Gai /o-coupled receptors (M2 muscarinic 
acetylcholine) and Gas-coupled receptors (~2 adrenergic and DI dopamine receptor) 
have no apparent effects on Cavl.3 activity . These results suggest that, in vivo, Cayl.3 
may be modulated exclusively by Gaq / 11-coupled GPCRs . This information may 
ultimately be useful in identifying pharmacological treatments for cardiac arrhythmias 
and disorders of hearing or insulin secretion. 
Introduction 
Voltage-gated Ca2+ channels consist 
of a pore-forming a 1 subunit and accessory 
a 28, ~ and y subunits (Figure 1) (Bell et al., 
2001). There are a variety of different types 
of voltage-gated Ca2+ channels classified by 
differences in the pore-forming (a 1) subunit 
(Lipscombe et al., 2004). L-type Ca2+ 
Figure 1 
channels are generally distinguished by their sensitivity to 1 ,4-dihydropyridine (DHP) 
compounds such as nifedipine . They have also been characterized by high voltage 
activation , relatively slow activation kinetics , large single channel conductance , and long 
lasting currents that show little voltage -dependent inactivation. However , not all of these 
generalizations hold true for the L-type channel Cayl.3, previously known as alD (Ertel 
et al., 2000). Cayl.3 has been shown to open much faster (time constant 0.1-0.5 ms) and 
at membrane potentials 25 m V more negative than other L-type channels (Kaschak et al., 
2002; Xu & Lipscombe, 2001; Zidanic & Fuchs, 1995). Relating to DHP sensitivity, 
Cav 1.3 is sensitive to nifedipine and nicardipine (Bell et al., 2001 ), but less sensitive to 
nimidopine than other L-type channels (Xu & Lipscombe, 2001). 
Cav 1.3 has been implicated in the activity of many types of excitable cells of 
mammalian tissues, such as the cardiac conduction system. Previous studies have shown 
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that Cayl.3 is present in the sino-atrial and atrio-ventricular nodes, but absent from the 
ventricles (Marionneau et al., 2005; Que et al., 2004). It has also been demonstrated that 
Cav 1.3 is important in maintaining pacemaker potentials in sino-atrial node cells 
(Mangoni et al., 2003). Experiments with Cavl.3 knockout mice show bradycardia and 
spontaneous sino-atrial node arrhythmia (Platzer et al., 2000) . 
Deafness is another symptom in Cavl.3 knockout mice (Platzer et al., 2000) . 
Other studies confirm the vital role of Cav 1.3 in auditory signaling of cochlear hair cells 
(Kollmar et al., 1997). Cav 1.3 has also been identified in rat hippocampal neurons where 
it links to a signaling complex involving a member of the Shank protein family (Zhang et 
al., 2005), and helps modulate small-conductance calcium-activated potassium channels 
(Bowden et al., 2001). In cerebellar neurons Cavl.3 channel expression was shown to be 
partially dependent on the presence of nitric oxide (Kim et al., 2005) . In spinal cord 
injuries, Li and Bennet (2003) found Cavl.3 to be a major contributor to motor neuron 
plateau potentials, which cause spasms in muscles served by the portion of the spinal cord 
below the injury . Another area where Cavl.3 channels play an important role is in insulin 
secretion by pancreatic p cells (Scholze et al., 2005; Lui et al., 2004). 
Even though Cav 1.3 has an important role in many types of excitatory cells, very 
little is known about its modulation . Using an HEK293 expression system Bell et al. 
(2001) found no modulation of Cayl.3 by forskolin, which activates adenylyl cyclase, a 
component in the Gas signaling pathway, or GTP yS, an indiscriminate activator of G 
proteins. The same study also found no modulation of Cayl.3 by somatostatin 2 receptor 
(Gai/o-coupled) or D2 dopamine receptor (both Gai/o-coupled and Gaq-coupled). 
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However, Scholze et al. (2005) recently reported experiments showing activation of 
Cavl .3 in Xenopus oocytes by the Gai /o-coupled µ opioid receptor. Also, Olson et al. 
(2005) demonstrated modulation in striatal neurons by D2 dopamine receptor as well as 
the Gaq/11-coupled Ml muscarinic acetylcholine receptor. Our experiments begin to 
address these apparently conflicting results by investigating modulation of Cav 1.3 by 
GPCRs that couple to Gaq /11, Gai /o, or Gas . 
Methods 
Cell Culture and Transfection. All experiments were performed using Human 
Embryonic Kidney (HEK) 293 cells obtained from American Type Culture Collection 
(Manassas , VA). Cells were grown in media containing 90% Dulbecco's modified 
Eagle's medium (Invitrogen, Carlsbad, CA), 10% fetal bovine serum (Hyclone 
Laboratories , Logan, UT) and 50 µg/ml Gentamycin. Transfection was accomplished 
using the calcium phosphate (CaPO4) precipitation technique. One day prior to 
transfection, cells were briefly trypsinized and re-plated onto 60 mm culture dishes at 
~40% confluence. Expression plasmids encoding Cayl.3 , a28b , P3 and a single GPCR 
were used at a concentration of 1.5 µg each per 60 mm culture dish. A parallel 
transfection with Cay2.2 instead of Cav 1.3 was performed during experiments with p2 
adrenergic receptor to confirm receptor expression and agonist activation . In all 
transfections a plasmid encoding enhanced green fluorescent protein (EGFP) was used as 
an expression marker at a concentration of 0.15 µg per 60 mm culture dish. Transfected 
cells were shocked with a glycerol-containing saline solution 5-7 hours after addition of 
the CaPO4-DNA mixture. On the day following transfection cells were again briefly 
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trypsinized and re-plated at low density onto 12 mm round glass coverslips . Patch-clamp 
recordings were made two days following transfection . 
Whole-cell Patch-Clamp Recording . Recordings were made in high calcium Ringer's 
solution containing (in mM) 140 NaCl, 2 KCl, 40 CaCli and 10 Hepes, with pH adjusted 
to 7.4 using NaOH. Borosilicate glass micropipettes were pulled to a resistance of 1.0-
2.0 Mn and were filled with an internal solution containing (in mM) 155 CsCl, 9 Csz-
EGTA, 4 Mg-ATP and 0.3 Tris-GTP, with pH adjusted to 7.4 using CsOH. After 
obtaining a gigaohm seal and breaking through the cell membrane, we used a steady 
holding potential of -90 mV. A series of brief (25 ms) rectangular depolarizations from -
90 to -30 through 80 mV was used to determine expression of Cavl.3. Modulation of 
Cay 1.3 was examined by repetitively evoking peak inward currents with brief ( 10 ms) 
depolarizations to +20 mV delivered at 0.2 Hertz. 
Receptors and Agonists. We tested the following Gaq / 11-coupled GPCRs and their 
corresponding agonists: alA adrenergic receptor (1 µM norepinephrine), Hl histamine 
receptor (100 µM histamine), Ml muscarinic acetylcholine receptor (1 mM carbachol), 
and NKl receptor (1 µM neurokinin A). We also tested the Gai/o-coupled M2 
muscarinic acetylcholine receptor (50 µM carbachol), the Gas-coupled D1 dopamine 
receptor (10 µM 3-hydroxytyramine), and the Gas-coupled p2 adrenergic receptor (1 µM 
isoproterenol). In each case the agonist concentration used had been previously 
determined to evoke maximal GPCR activation. 
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Results 
Figure 2. Cav 1.3 is inhibited by Gaq/11-coupled GPCRs. 
Representative data from an HEK.293 cell coexpressing 
Cayl.3 and NK.1 receptors. Top, individual calcium 
current amplitudes are plotted as a function of time. 
Bottom, individual whole-cell calcium currents recorded 
at the times indicated in the time-plot. Currents were 
evoked by 10 ms step depolarizations to +20 mV. 
















(NKA). During a typical experiment with a Gaq/11-
coupled GPCR, calcium currents with similar amplitudes 
Figure 2 
were evoked during the first depolarizations before agonist application (#1 in Figure 2). 
After agonist application, the current amplitude decreased with each subsequent 
depolarization until maximal inhibition was reached (~30 s, see #2), at which point the 
agonist solution was replaced by saline bath solution . Over the next few minutes as the 
agonist was washed away from the cell, GPCR mediated inhibition decreased and the 
current amplitudes evoked increased toward pre-inhibition levels (~3 min, see #3). We 
found washout to be very slow and incomplete, with current amplitudes never fully 
recovering to pre-inhibition levels. Very similar patterns of channel inhibition were 
observed in cells coexpressing other Gaq/11-coupled GPCRs (see data summary in 
Figure 4). 
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Figure 3. Cayl.3 is not inhibited by Gas-coupled or Gai /o-coupled GPCRs. 
Representative data from an HEK.293 cell 
coexpressing Cav 1.3 and D 1 dopamine receptors. 
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same manner as described above with Gaq/11-coupled GPCRs. However, in the case of 
Gas-coupled and Gai /o-coupled GPCRs, agonist application produced no significant 
change in calcium current amplitude . Similar patterns were observed in cells 
coexpressing the other Gas-coupled or Gai /o-coupled GPCRs (see data summary in 
Figure 4). 
Figure 4. Summary of Results 
Histobars indicate the average inhibition 
of Cav 1.3 currents by each of the GPCRs 
tested. Error bars indicate S.E.M. All 
Gaq / 11-coupled receptors inhibited 

















Gai/o-coupled and Gas-coupled receptors appeared not to trigger significant modulation 
of Cav 1.3. The D 1 dopamine receptor triggered slight stimulation of Cav 1.3. Results 
with P2 adrenergic receptor are very preliminary as the experiments conducted with this 
receptor yielded low-quality recordings that could not be interpreted with confidence . 
Discussion 
Profound inhibition of Cav 1.3 by each of the Gaq/11-coupled receptors tested 
(alA-AR, Hl, Ml, and NKI receptors) demonstrates that a Gaq/11-coupled signaling 
pathway is capable of inhibiting Cav 1.3. This finding agrees well with the previously 
demonstrated modulation of Cavl.3 by Ml muscarinic acetylcholine and D2 dopamine 
receptors found by Olson et al. (2005). 
We also found a general lack of modulation by Gas- or Gai/o- coupled receptors, 
suggesting that Cav 1.3 may be modulated exclusively by Gaq / 11- coupled receptors, in 
vivo. Lack of good recordings with the p2 adrenergic receptor and slight activation in 
cells coexpressing Dl dopamine receptor make these findings fairly preliminary , but 
additional experiments should confirm the preliminary conclusion that Cav 1.3 is not 
modulated by Gas- or Gai/o- coupled receptors. While these results add strength to the 
previous study (Bell et al., 2001) showing a lack of modulation by Gai/o- coupled 
GPCRs, they appear to conflict with the recent study by Scholze et al. (2005) showing 
modulation of Cav 1.3 by Gai /o- coupled receptors in Xenopus oocytes. An explanation 
for these differing findings could be that some cells, such as Xenopus oocytes, contain 
additional proteins which are necessary for modulation of Cav 1.3 by Gai/o-coupled 
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receptors, but which are not expressed in HEK293 cells. This possibility could easily be 
investigated by repeating our current study in Xenopus oocytes. 
The present study shows inhibition of Cav 1.3 by Gaq/11-coupled receptors. This 
inhibition exhibits slow onset and recovery, a pattern of inhibition very similar to the 
previously characterized slow muscarinic inhibition (SMI) of Cav 1.2a, another L-type 
calcium channel, by Ml receptors (Bannister et al., 2002). This similarity suggests that 
the inhibition of Cav 1.3 by Gaq/11-coupled receptors is also "slow" inhibition mediated 
by the Ga subunit. To investigate this, future experiments will use regulator of G protein 
signaling 3T (RGS3T) to uncouple Gaq/11 from the receptor and block any modulation 
by Gaq/11-coupled receptors. IfRGS3T eliminates receptor inhibition the role of 
Gaq/11 in Cav 1.3 inhibition will be supported . To rule out a role of Gpy subunits we 
will use agents, such as rod transducin (Gat) or the carboxyl-terminal region of G 
protein-coupled receptor kinase 2 (GRK2ct), which bind Gpy subunits and prevent them 
from signaling. A change in GPCR modulation of Cavl.3 caused by the presence of Gat 
or GRK2ct would indicate that Gpy plays a role in Cavl.3 modulation. Based on 
previous results ( e.g., Bannister et al., 2002), we do not expect Gat or GRK2ct to produce 
any change. 
The results we present here begin to clarify the role of different GPCRs in Cav 1.3 
modulation. This knowledge will be useful in understanding the various physiological 
processes where Cav 1.3 is involved. Development of pharmacological treatments for 
cardiac arrhythmias, motor neuron spasms, and disorders in hearing and insulin secretion 
will also benefit. 
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